Published in Virchows Arch on December 28, 2013
Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens. J Am Soc Nephrol (2015) 0.81
Proteomics for rejection diagnosis in renal transplant patients: Where are we now? World J Transplant (2016) 0.76
Current status of pediatric renal transplant pathology. Pediatr Nephrol (2016) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet (2012) 4.85
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant (2007) 2.25
Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol (2002) 1.84
The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant (2011) 1.60
Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant (2013) 1.57
Heterogeneity in endothelial cells from large vessels and microvessels. Differentiation (1987) 1.31
Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema. Transplantation (1996) 1.12
Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol (1997) 1.11
Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. J Am Soc Nephrol (2011) 1.07
Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study. Am J Transplant (2013) 1.00
Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring. Am J Transplant (2010) 0.98
Diversity in unity: the biochemical composition of the endothelial cell surface varies between the vascular beds. Microsc Res Tech (2002) 0.96
Heterogeneity of endothelial function within the circulation. Curr Opin Nephrol Hypertens (1998) 0.91
Defining the canonical form of T-cell-mediated rejection in human kidney transplants. Am J Transplant (2010) 0.90
Acute vascular rejection after renal transplantation and isolated v-lesion. Clin Transplant (2012) 0.88
Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection. Clin J Am Soc Nephrol (2008) 0.84
An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome. Nephrol Dial Transplant (1999) 0.82
Heterogeneity in the distribution of actin filaments in the endothelial cells of arteries and arterioles in the rat kidney. Eur J Cell Biol (1993) 0.78
Why rejections are not biopsy proven: frequency and reasons. Transplant Proc (2010) 0.75
The renal arterial resistance index and renal allograft survival. N Engl J Med (2003) 4.36
The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest (2003) 3.71
Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol (2010) 2.71
Pathogenesis and management of hypertension after kidney transplantation. J Hypertens (2011) 2.66
Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med (2007) 2.14
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation (2003) 1.79
Complement 5a receptor inhibition improves renal allograft survival. J Am Soc Nephrol (2008) 1.72
Aftercare for patients with transplanted organs. Dtsch Arztebl Int (2009) 1.72
A wild zebra chase. Nephrol Dial Transplant (2007) 1.60
Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant (2005) 1.54
Acute kidney injury due to deferoxamine in a renal transplant patient. Nephrol Dial Transplant (2007) 1.40
Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrol Dial Transplant (2003) 1.40
Effect of incomplete parathyroidectomy preserving entire parathyroid glands on renal graft function. Arch Surg (2011) 1.38
Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant (2005) 1.37
Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience. Nephrol Dial Transplant (2011) 1.36
Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome. J Am Soc Nephrol (2007) 1.30
Safety and adequacy of renal transplant protocol biopsies. Am J Transplant (2005) 1.30
The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic Biol Med (2004) 1.30
Quality of life in adult transplant recipients more than 15 years after kidney transplantation. Transplantation (2006) 1.28
Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study. Kidney Int (2005) 1.27
Long-term effects of acute ischemia and reperfusion injury. Kidney Int (2004) 1.26
Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant (2005) 1.24
Transcriptional regulation of heme oxygenase-1 gene expression by MAP kinases of the JNK and p38 pathways in primary cultures of rat hepatocytes. J Biol Chem (2003) 1.22
Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection. Crit Care (2011) 1.21
Anaesthesia and Parkinson's disease: how to manage with new therapies? Curr Opin Anaesthesiol (2009) 1.15
Inhibition and genetic deficiency of p38 MAPK up-regulates heme oxygenase-1 gene expression via Nrf2. J Immunol (2009) 1.09
Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis. Kidney Int (2005) 1.05
CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome. Biol Blood Marrow Transplant (2013) 1.05
Results of combined and sequential liver-kidney transplantation. Liver Transpl (2003) 1.03
Regulation of heme oxygenase-1 gene transcription: recent advances and highlights from the International Conference (Uppsala, 2003) on Heme Oxygenase. Antioxid Redox Signal (2004) 1.03
Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J Am Soc Nephrol (2008) 1.03
Elevated numbers of circulating endothelial cells in renal transplant recipients. Transplantation (2003) 1.00
Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months. Nephrol Dial Transplant (2009) 1.00
Diagnosis of subclinical and clinical acute T-cell-mediated rejection in renal transplant patients by urinary proteome analysis. Proteomics Clin Appl (2011) 0.99
Bruton's tyrosine kinase is required for TLR-dependent heme oxygenase-1 gene activation via Nrf2 in macrophages. J Immunol (2011) 0.99
Regulation of rat heme oxygenase-1 expression by interleukin-6 via the Jak/STAT pathway in hepatocytes. J Hepatol (2006) 0.98
Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly? Front Pharmacol (2012) 0.97
Role of NF-kappaB and p38 MAP kinase signaling pathways in the lipopolysaccharide-dependent activation of heme oxygenase-1 gene expression. Antioxid Redox Signal (2004) 0.94
Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor. PLoS One (2013) 0.94
Rothmund-Thomson syndrome--a single case report with systemic muscular atrophy, multiple organ fibrosis and pulmonary cachexia. Rheumatology (Oxford) (2012) 0.93
Characteristics of testicular dysgenesis syndrome and decreased expression of SRY and SOX9 in Frasier syndrome. Mol Reprod Dev (2008) 0.93
Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage. Hypertension (2003) 0.92
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study. Transpl Int (2014) 0.92
High-dose erythropoietin has no effect on short- or long-term graft function following deceased donor kidney transplantation. Kidney Int (2011) 0.91
Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract. World J Gastroenterol (2010) 0.91
Biology of heme in health and disease. Curr Med Chem (2004) 0.91
Necrotizing fasciitis and acute kidney injury in a patient with acute myelogenous leukemia-case presentation and review of the literature. Ann Hematol (2010) 0.91
Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection. Hepatology (2014) 0.91
Health-related quality of life after solid organ transplantation: a prospective, multiorgan cohort study. Transplantation (2013) 0.90
Indicators of treatment responsiveness to rituximab and plasmapheresis in antibody-mediated rejection after kidney transplantation. Transplantation (2015) 0.89
Simvastatin-dependent up-regulation of heme oxygenase-1 via mRNA stabilization in human endothelial cells. Eur J Pharm Sci (2010) 0.89
Glomerular mRNA expression of prothrombotic and antithrombotic factors in renal transplants with thrombotic microangiopathy. Transplantation (2013) 0.89
Local complement C3 expression is upregulated in humoral and cellular rejection of renal allografts. Am J Transplant (2005) 0.89
HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells. PLoS One (2012) 0.89
Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literature. Rare Tumors (2012) 0.88
Living kidney donors >60 years of age: is it acceptable for the donor and the recipient? Transpl Int (2006) 0.87
An atypical NF-kappa B-regulated pathway mediates phorbol ester-dependent heme oxygenase-1 gene activation in monocytes. J Immunol (2008) 0.87
Bβ(15-42) attenuates the effect of ischemia-reperfusion injury in renal transplantation. J Am Soc Nephrol (2011) 0.87
Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation. Cardiovasc Res (2006) 0.85
Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection. Kidney Int (2010) 0.85
Quantitative MRI shows cerebral microstructural damage in hemolytic-uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI. Neuroradiology (2013) 0.85
Urinary NGAL Ratio Is Not a Sensitive Biomarker for Monitoring Acute Tubular Injury in Kidney Transplant Patients: NGAL and ATI in Renal Transplant Patients. J Transplant (2012) 0.84
Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation. Transpl Int (2009) 0.84
Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. J Biol Chem (2003) 0.84
Angiopoietin-2 modulates eEOC-mediated renoprotection in AKI in a dose-dependent manner. J Nephrol (2013) 0.84
Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysis. J Med Virol (2008) 0.84
Heme oxygenase-1 gene activation by the NAD(P)H oxidase inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride via a protein kinase B, p38-dependent signaling pathway in monocytes. J Biol Chem (2005) 0.83
Kidney transplantation in a patient with severe adenine phosphoribosyl transferase deficiency: obstacles and pitfalls. Transpl Int (2010) 0.83
Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol (2002) 0.83
Semaphorin 3A alters endothelial cell immunogenicity by regulating Class II transactivator activity circuits. Transfusion (2014) 0.82
Role of xanthine oxidoreductase in experimental acute renal-allograft rejection. Transplantation (2004) 0.82
Bone morphogenetic protein-5 and early endothelial outgrowth cells (eEOCs) in acute ischemic kidney injury (AKI) and 5/6-chronic kidney disease. Am J Physiol Renal Physiol (2013) 0.82
A swollen neck. Lancet (2002) 0.81
Opposite expression of the antioxidant heme oxygenase-1 in primary cells and tumor cells: regulation by interaction of USF-2 and Fra-1. Antioxid Redox Signal (2008) 0.81
Secreted semaphorin 5A activates immune effector cells and is a biomarker for rheumatoid arthritis. Arthritis Rheumatol (2014) 0.81
Optimized RNA extraction from non-deparaffinized, laser-microdissected material. Methods Mol Biol (2011) 0.81
A comparison of the outcome of pregnancies after liver and kidney transplantation. Transplantation (2013) 0.80
Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequencies. J Transl Med (2011) 0.80
Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS). Virchows Arch (2013) 0.80
Toll-like receptor 2 and renal allograft function. Am J Nephrol (2008) 0.80
Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection. Transpl Int (2004) 0.80